Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kramar

Showing results (451-460 of 543) with videos related to

Pageof 55
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 19, 2007
UGT1A1 polymorphism can predict hematologic toxicity in patients treated with irinotecanJean-François Côté, Sylvain Kirzin, Andrew Kramar, et al.
The Oncologist|October 22, 2011
Cetuximab plus FOLFIRINOX (ERBIRINOX) as first-line treatment for unresectable metastatic colorectal cancer: a phase II trialEric Assenat, Francoise Desseigne, Simon Thezenas, et al.
Cancer Research|August 28, 2003
Identification and pharmacological characterization of SRBP-2: a novel SR31747A-binding proteinHubert Vidal, Guillaume Mondesert, Sylvaine Galiègue, et al.
Cancers|July 20, 2021
Fibroblast Activation Protein Expressing Mesenchymal Cells Promote Glioblastoma AngiogenesisEva Balaziova, Petr Vymola, Petr Hrabal, et al.
Physiological Research|November 5, 2013
Cardiac surgery increases serum concentrations of adipocyte fatty acid-binding protein and its mRNA expression in circulating monocytes but not in adipose tissueT Kotulak, J Drapalova, M Lips, et al.
Science Advances|August 13, 2025
Transcriptome fingerprinting of aberrant fibroblast activation unlocks effective therapeutics to tackle cardiac fibrosisMathieu Cinato, Ryeonshi Kang, Solomiia Kramar, et al.
International Journal of Radiation Oncology, Biology, Physics|April 14, 2010
Quality of life assessment after concurrent chemoradiation for invasive bladder cancer: results of a multicenter prospective study (GETUG 97-015)Jean-Léon Lagrange, Caroline Bascoul-Mollevi, Lionnel Geoffrois, et al.
Clinical Epigenetics|January 29, 2025
Validating a clinically based MS-MLPA threshold through comparison with Sanger sequencing in glioblastoma patientsHalka Lhotska, Karolina Janeckova, Hana Cechova, et al.
Pathology Oncology Research : POR|November 13, 2024
Diagnostic challenges in complicated case of glioblastomaTatiana Aghova, Halka Lhotska, Libuse Lizcova, et al.
Journal of Cardiovascular Pharmacology|January 1, 1987
Placebo-controlled study of lisinopril in congestive heart failure: a multicentre studyJ P Chalmers, M J West, J Cyran, et al.
Pageof 55

Showing results (451-460 of 543) with videos related to

Sort By:
Pageof 55
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 19, 2007
UGT1A1 polymorphism can predict hematologic toxicity in patients treated with irinotecanJean-François Côté, Sylvain Kirzin, Andrew Kramar, et al.
The Oncologist|October 22, 2011
Cetuximab plus FOLFIRINOX (ERBIRINOX) as first-line treatment for unresectable metastatic colorectal cancer: a phase II trialEric Assenat, Francoise Desseigne, Simon Thezenas, et al.
Cancer Research|August 28, 2003
Identification and pharmacological characterization of SRBP-2: a novel SR31747A-binding proteinHubert Vidal, Guillaume Mondesert, Sylvaine Galiègue, et al.
Cancers|July 20, 2021
Fibroblast Activation Protein Expressing Mesenchymal Cells Promote Glioblastoma AngiogenesisEva Balaziova, Petr Vymola, Petr Hrabal, et al.
Physiological Research|November 5, 2013
Cardiac surgery increases serum concentrations of adipocyte fatty acid-binding protein and its mRNA expression in circulating monocytes but not in adipose tissueT Kotulak, J Drapalova, M Lips, et al.
Science Advances|August 13, 2025
Transcriptome fingerprinting of aberrant fibroblast activation unlocks effective therapeutics to tackle cardiac fibrosisMathieu Cinato, Ryeonshi Kang, Solomiia Kramar, et al.
International Journal of Radiation Oncology, Biology, Physics|April 14, 2010
Quality of life assessment after concurrent chemoradiation for invasive bladder cancer: results of a multicenter prospective study (GETUG 97-015)Jean-Léon Lagrange, Caroline Bascoul-Mollevi, Lionnel Geoffrois, et al.
Clinical Epigenetics|January 29, 2025
Validating a clinically based MS-MLPA threshold through comparison with Sanger sequencing in glioblastoma patientsHalka Lhotska, Karolina Janeckova, Hana Cechova, et al.
Pathology Oncology Research : POR|November 13, 2024
Diagnostic challenges in complicated case of glioblastomaTatiana Aghova, Halka Lhotska, Libuse Lizcova, et al.
Journal of Cardiovascular Pharmacology|January 1, 1987
Placebo-controlled study of lisinopril in congestive heart failure: a multicentre studyJ P Chalmers, M J West, J Cyran, et al.
Pageof 55